Fridays vs Ro
Ro costs $100 less a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →If you are choosing between Fridays and Ro, the first difference is cost: Ro is $100 a month cheaper at the entry price. Ro leads our six-part score, 6.7 to 5.5.
Fridays vs Ro price
Ro is the cheaper way in: $149 a month against $249 a month at Fridays. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.
Medications and formats
Fridays and Ro do not overlap on medication; only Fridays lists semaglutide and tirzepatide; only Ro lists orforglipron.
On format, Fridays prices compounded injections and brand-name pens, while Ro prices brand-name pens.
Where each one treats patients
Neither Fridays nor Ro publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Fridays
Ro
Additional membership fees apply
What each price covers
Both prices cover the clinician visit and coaching.
Fridays' price also covers the medication itself, which Ro does not claim.
Ro's price also covers lab work, which Fridays does not claim.
Fridays is silent on shipping and lab work.
Ro is silent on shipping.
That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Ro scores 6.7 and Fridays 5.5 out of 10.
Fridays is stronger on effectiveness (10.0 vs 8.0) and support (7.0 vs 5.5).
Ro is stronger on value (5.0 vs 2.8), user experience (8.0 vs 3.0) and trust & safety (8.0 vs 4.0).
Accessibility is within half a point.
Fridays
5.5/10
Ro
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor Ro has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Ro |
|---|---|---|
| Starting Price | $249/mo | ✓$149/mo |
| Features | 2 features | ✓7 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Our Verdict
Ro wins this one, 6.7 to 5.5, above all for knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC. It also costs $100 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Fridays vs Ro: FAQ
Close alternatives to Fridays and Ro
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Ro vs Amazon One Medical
- Ro vs LillyDirect Foundayo
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.